Company Filing History:
Years Active: 2011
Title: Innovations of Meyyappan Muthuppalniappan
Introduction
Meyyappan Muthuppalniappan is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific biological pathways.
Latest Patents
Muthuppalniappan holds a patent for "Quinazolinedione derivatives as TRPA1 modulators." This invention provides Quinazolinedione derivatives that act as modulators for TRPA (Transient Receptor Potential subfamily A). The compounds described in this patent are particularly useful for treating or preventing diseases, conditions, and disorders modulated by TRPA1. The patent also outlines processes for preparing these compounds, intermediates used in their synthesis, pharmaceutical compositions, and methods for treating or preventing related diseases.
Career Highlights
Muthuppalniappan is currently associated with Glenmark Pharmaceuticals S.A., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic agents that can improve patient outcomes.
Collaborations
He has collaborated with notable colleagues such as Abraham Thomas and Sukeerthi Kumar, enhancing the research and development efforts within his team.
Conclusion
Meyyappan Muthuppalniappan's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the treatment of various diseases.